Does an Initially Authorised Combination Medicinal Product and a Later Authorised Single Component of that Combination Belong to the Same Global Marketing Authorization? - The Tecfidera® Judgment of the General Court in Case T-611/18

Guram Gobechia

DOI https://doi.org/10.21552/eplr/2021/2/7

Guram Gobechia is an Associate at Novacos Rechtsanwälte. For Correspondence: <guram.gobechia@novacos-law.com>

EPLR - European Pharmaceutical Law Review